SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is facing significant selling pressure as it dips below the $1 mark, triggering intense debate among retail investors regarding the project's long-term utility and future price direction. While bearish sentiment highlights concerns over token dilution and regulatory delays, many long-term holders and market observers are debating whether this price action represents a final capitulation or a strategic accumulation opportunity by institutional whales.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is seeing significant community discussion following a series of infrastructure milestones, including the acquisition of construction permits and increased capacity projections for its Texas data center project. While some investors are concerned by recent EPS misses and a lack of signed tenant contracts, sentiment remains polarized between bears highlighting financial volatility and bulls emphasizing the company's behind-the-meter energy strategy as a critical advantage in the AI infrastructure race.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors debate the impact of the company's shift back to net-buying of equities and aggressive share buybacks, with community sentiment split between those viewing the move as a return to form and critics dismissing the stock as stagnant dead money. Ongoing discussions center on leadership transitions and whether the company's massive cash pile should be deployed more effectively or distributed as dividends to provide better returns compared to current broad market benchmarks.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is attracting significant attention as investors anticipate a major earnings catalyst, with the community closely tracking the company's aggressive sovereign AI infrastructure expansion in Southeast Asia. Discussion remains heavily focused on the high short interest relative to the float and the potential for a volatile price move following upcoming financial results.

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is seeing significant market activity as investors speculate on potential Phase 3 clinical trial outcomes and the stock's position in the competitive retinal disease treatment sector. The community is actively debating the impact of upcoming trial readouts, institutional accumulation, and the potential for a short squeeze given the high short interest.

Paysafe Ltd. provides online payment solutions. The firm operates through the following segments: Merchant Solutions and Digital Wallet. The Merchant Solutions business segment focuses on card not present and card present solutions for small to medium size business merchants. The Digital Wallet business segment provides wallet based online payment solutions through its Skrill, eCash solutions and NETELLER brands. The company was founded in 1996 and is headquartered in London, the United Kingdom.

Paysafe Limited

Paysafe Limited is facing heavy selling pressure and skepticism from the community, with investors highlighting rising debt levels, a widening net loss, and frustration over executive stock compensation. While some traders discuss potential buyout interest or bottom-fishing opportunities, others continue to label the stock a failing SPAC scam, pointing to repeated guidance adjustments and consistent underperformance relative to broader market growth.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. is currently a focal point for investors tracking Bitcoin treasury stocks, with active community discussion centering on its unique daily dividend structure and treasury management strategies. Market participants are closely watching the company's capital allocation and the impact of broader sector volatility, as the stock remains a popular vehicle for traders seeking leveraged exposure to crypto-market trends.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is rallying as the company benefits from new government-backed tariffs on foreign drone imports and increased demand for domestic manufacturing. The community is actively discussing the stock's potential for a short squeeze and its long-term strategic role in the U.S. defense supply chain.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as investors capitalize on a landmark five-year cross-licensing deal with Samsung, fueling optimism that similar high-value settlements with other industry players like Micron will soon follow. The community is heavily focused on the company's strong patent position, potential for a short squeeze, and the prospects of a future Nasdaq relisting.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as investors digest record quarterly revenue and internal optimism surrounding the company's TIL therapy platform. The community is actively discussing the potential for a short squeeze, citing significant short interest and upcoming clinical catalysts in lung cancer as key drivers for potential long-term rerating.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abivax is rebounding following a severe sell-off triggered by concerns over malignancy data from its Phase 3 ulcerative colitis study, as institutional investors and analysts pivot to focus on strong efficacy results and the likelihood that these cancer cases are statistical noise rather than drug-induced. The community is actively debating the stock's potential as a major acquisition target, with many traders framing the recent price drop as an overreaction and a strategic buying opportunity ahead of anticipated safety updates and M&A activity.

Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross?

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet – Buyout Chatter Builds 

Equity

Abivax said underwriters have fully exercised their option to purchase an additional 960,000 American depositary shares as part of their $920 million offering.

Abivax Prices $800M Offering Of ADS – Here’s A Look At Some Key Figures

The size of the offering was increased to $800 million from the previously announced offering of $600 million in ADSs.

ABIVAX Announces Pricing Of $800 Mln Offering Of ADS

(RTTNews) - Wednesday, ABIVAX Soci?t? Anonyme (ABVX) announced the pricing of an underwritten public offering of 6.4 million American Depositary Shares or ADSs, each representing one ordinary share, 0.01 nominal value per share, of the company, for $125 per ADS...

ABVX Stock Clocks Best Day In 11 Months On Analyst Upgrades After Fresh Data Eases Drug Safety Concerns 

Wedbush, BTIG and Jefferies weighed in on ABVX on Tuesday after the company unveiled updated safety and efficacy data from an obefazimod study. 


AEVEX, Abivax, Watts Water Technologies And Other Big Stocks Moving Higher On Tuesday

Stocks up, Dow Jones +100 points. AEVEX Corp shares rose 11.8% on $50m Air Force contract. Other big gainers: ABVX +34.2%, ESBA +20.9%, AVAV +20.4%, AIRJ +17.4%, FCEL +14%, UMAC +11.1%, HSAI +10.7%, PROK +9.3%, WOLF +9.1%, APD +8.6%read more...

Why Is Abivax Stock Skyrocketing Tuesday?

Abivax (ABVX) stock skyrockets 36% following strong Phase 3 maintenance data for its ulcerative colitis treatment. Get the latest details.read more...

Stock Futures Flat As S&P Closes Out Best Quarter In 6 Years

Stock Futures Flat As S&P Closes Out Best Quarter In 6 Years

 US index futures erased an earlier gain following some belligerent Iran headlines, but are still set to end?a quarter that is set to be the S&P 500's best in six years with markets behaving as though period-end dynamics have...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion.
Cuprina Holdings (Cayman) (NASDAQ:CUPR) shares movedread more...

French biotech stock soars 25% after new data on experimental medicine

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease...

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

ABVXAbivax - ADR

Fundamentals

Connect Stocktwits to ChatGPT

Latest ABVX News